Antonio Toscano
Overview
Explore the profile of Antonio Toscano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
234
Citations
2875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pugliese A, Migliorato A, Barbaccia A, Biasini F, Musumeci O, Toscano A, et al.
Acta Myol
. 2024 Oct;
43(3):108-113.
PMID: 39468967
Objectives: Focal myositis (FM) is a rare and restricted skeletal muscle inflammation, presenting as a solid mass with a typical lower leg localization and benign prognosis. In most cases the...
12.
Leonardi M, Colonna I, Garcia-Azorin D, Bereczki D, Bodini B, Bregman N, et al.
Eur J Neurol
. 2024 Oct;
31(12):e16516.
PMID: 39429124
Background And Purpose: The European Academy of Neurology (EAN) has adhered to the global plan for reducing the burden of neurological disorders and promoting brain health launched by the World...
13.
van Kooten H, Horton M, Wenninger S, Babacic H, Schoser B, Lefeuvre C, et al.
Eur J Neurol
. 2024 Aug;
31(12):e16397.
PMID: 39205420
Background And Purpose: The Rasch-Built Pompe-Specific Activity (R-PAct) scale is a patient-reported outcome measure specifically designed to quantify the effects of Pompe disease on daily life activities, developed for use...
14.
Bortolani S, Savarese M, Vattemi G, Bonanno S, Falzone Y, Pugliese A, et al.
Neurology
. 2024 Aug;
103(4):e209697.
PMID: 39102614
Background And Objectives: The diagnostic process for myofibrillar myopathies (MFM) and distal myopathies (DM) is particularly complex because of the large number of causative genes, the existence of still molecularly...
15.
Monceau A, Nath R, Suarez-Calvet X, Musumeci O, Toscano A, Kierdaszuk B, et al.
Brain
. 2024 Jul;
147(12):4213-4226.
PMID: 39045638
Late-onset Pompe disease (LOPD) is a rare genetic disorder caused by the deficiency of acid alpha-glucosidase leading to progressive cellular dysfunction owing to the accumulation of glycogen in the lysosome....
16.
Schoser B, van der Beek N, Broomfield A, Brusse E, Diaz-Manera J, Hahn A, et al.
Eur J Neurol
. 2024 Jun;
31(9):e16383.
PMID: 38873957
Background And Purpose: Two novel enzyme replacement therapies (ERTs), studied in phase 3 trials in late-onset Pompe patients, reached marketing authorization by the European Medicines Agency in 2022 and 2023....
17.
Ferrau L, Giammello F, Tessitore A, Casella C, Iati D, Ciacciarelli A, et al.
World Neurosurg
. 2024 Jun;
188:e382-e389.
PMID: 38823443
Objective: The optimal management and procedural strategy for tandem occlusion (TO) in acute ischemic stroke are still unclear, as is the long-term outcome of these patients. The aim of this...
18.
Schirinzi E, Bochicchio M, Lochmuller H, Vissing J, Jordie-Diaz-Manerae , Evangelista T, et al.
J Neuromuscul Dis
. 2024 May;
PMID: 38728200
Neuromuscular diseases (NMDs), in their phenotypic heterogeneity, share quite invariably common issues that involve several clinical and socio-economical aspects, needing a deep critical analysis to develop better management strategies. From...
19.
Toscano A, Giunta M, Capuano P, Balzani E, Salonia C, Balzano S, et al.
Ann Card Anaesth
. 2024 May;
27(1):93-94.
PMID: 38722135
No abstract available.
20.
Schoser B, Raben N, Varfaj F, Walzer M, Toscano A
Mol Genet Metab Rep
. 2024 May;
39:101085.
PMID: 38698877
Pompe disease is a rare genetic disorder characterized by a deficiency of acid α-glucosidase (GAA), leading to the accumulation of glycogen in various tissues, especially in skeletal muscles. The disease...